• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学可切除或临界可切除胰腺腺癌患者无效手术的术前预测

Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma.

作者信息

Lee Hee Seung, An Chansik, Hwang Ho Kyoung, Roh Yun Ho, Kang Huapyong, Jo Jung Hyun, Chung Moon Jae, Park Jeong Youp, Kang Chang Moo, Park Seung Woo, Yoon Dong Sup, Lee Woo Jung, Song Si Young, Bang Seungmin

机构信息

Department of Internal Medicine, Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.

Department of Radiology, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Korea.

出版信息

J Gastroenterol Hepatol. 2020 Mar;35(3):499-507. doi: 10.1111/jgh.14837. Epub 2019 Sep 3.

DOI:10.1111/jgh.14837
PMID:31425643
Abstract

BACKGROUND AND AIM

The aim of this study is to identify the predictive factors for futile surgery in patients with radiologically resectable or borderline resectable pancreatic cancer and to develop a prediction model.

METHODS

This retrospective study included patients who underwent pancreatic surgery for pancreatic cancer between 2006 and 2017. To identify independent risk factors for futile surgery, logistic regression and random forest analyses were performed in the training cohort, based on which a nomogram was established. The predictive accuracy and discriminative ability of the nomogram were validated in the validation cohort.

RESULTS

Of 389 patients who underwent pancreatic surgery, the laparotomy was futile in 40 patients (10.3%). In the training cohort, the univariate and multivariate logistic regression analyses revealed that serum carbohydrate antigen 19-9 level of ≥ 150 U/mL (P = 0.003), the presence of suspicious lymph node (P = 0.013), and more extensive peripancreatic tumor infiltration (P < 0.001) were independent predictive factors for futile surgery. The bootstrap-corrected concordance index of the nomogram was high in the training cohort, 0.826 with a 95% confidence interval of 0.745-0.907. This model also showed a good discriminative performance in the validation cohort, with a concordance index of 0.831.

CONCLUSIONS

We established and validated a novel nomogram that predicts the risk of futile surgery due to occult distant metastasis in patients with radiologically resectable or borderline resectable pancreatic cancer.

摘要

背景与目的

本研究旨在确定影像学上可切除或临界可切除胰腺癌患者进行无意义手术的预测因素,并建立预测模型。

方法

这项回顾性研究纳入了2006年至2017年间因胰腺癌接受胰腺手术的患者。为了确定无意义手术的独立危险因素,在训练队列中进行了逻辑回归和随机森林分析,并在此基础上建立了列线图。在验证队列中验证了列线图的预测准确性和判别能力。

结果

在389例行胰腺手术的患者中,40例(10.3%)剖腹手术无意义。在训练队列中,单因素和多因素逻辑回归分析显示,血清糖类抗原19-9水平≥150 U/mL(P = 0.003)、存在可疑淋巴结(P = 0.013)以及胰腺周围肿瘤浸润范围更广(P < 0.001)是无意义手术的独立预测因素。列线图在训练队列中的自抽样校正一致性指数较高,为0.826,95%置信区间为0.745 - 0.907。该模型在验证队列中也显示出良好的判别性能,一致性指数为0.831。

结论

我们建立并验证了一种新型列线图,可预测影像学上可切除或临界可切除胰腺癌患者因隐匿性远处转移导致无意义手术的风险。

相似文献

1
Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma.影像学可切除或临界可切除胰腺腺癌患者无效手术的术前预测
J Gastroenterol Hepatol. 2020 Mar;35(3):499-507. doi: 10.1111/jgh.14837. Epub 2019 Sep 3.
2
A preoperative nomogram predicts prognosis of up front resectable patients with pancreatic head cancer and suspected venous invasion.术前列线图预测可直接切除的胰头癌合并可疑静脉侵犯患者的预后。
HPB (Oxford). 2018 Nov;20(11):1034-1043. doi: 10.1016/j.hpb.2018.04.010. Epub 2018 Jun 19.
3
Predictors of distant metastasis on exploration in patients with potentially resectable pancreatic cancer.可切除性胰腺癌患者术中远处转移的预测因素
BMC Gastroenterol. 2018 Nov 6;18(1):168. doi: 10.1186/s12876-018-0891-y.
4
A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics.术前临床数据和 CT 特征预测可切除胰腺导管腺癌(PDAC)患者 upfront 手术后复发的模型。
BMC Med Imaging. 2022 Jul 3;22(1):116. doi: 10.1186/s12880-022-00823-4.
5
Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study.可切除胰腺癌早期复发预测的列线图模型:一项多中心研究。
Medicine (Baltimore). 2024 Mar 8;103(10):e37440. doi: 10.1097/MD.0000000000037440.
6
Estimating Recurrence after Upfront Surgery in Patients with Resectable Pancreatic Ductal Adenocarcinoma by Using Pancreatic CT: Development and Validation of a Risk Score.基于胰腺 CT 预测可切除胰腺导管腺癌患者根治性手术后复发风险的评分系统:开发与验证。
Radiology. 2020 Sep;296(3):541-551. doi: 10.1148/radiol.2020200281. Epub 2020 Jul 14.
7
A simple risk score for detecting radiological occult metastasis in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma.一种用于检测可切除或交界可切除胰腺导管腺癌患者隐匿性远处转移的简单风险评分。
J Hepatobiliary Pancreat Sci. 2022 Feb;29(2):262-270. doi: 10.1002/jhbp.1026. Epub 2021 Aug 24.
8
Clinical Predictors of Unresectable Disease at Laparotomy in Patients With Pancreatic Ductal Adenocarcinoma Planning to Undergo Surgical Resection.在计划接受手术切除的胰腺导管腺癌患者中,剖腹手术时无法切除疾病的临床预测因素。
Anticancer Res. 2021 Oct;41(10):5171-5177. doi: 10.21873/anticanres.15335.
9
Selective use of staging laparoscopy based on carbohydrate antigen 19-9 level and tumor size in patients with radiographically defined potentially or borderline resectable pancreatic cancer.基于肿瘤标志物 CA19-9 水平和肿瘤大小对影像学界定的潜在可切除或交界可切除胰腺癌患者行分期腹腔镜检查的选择性应用。
Pancreas. 2011 Apr;40(3):426-32. doi: 10.1097/MPA.0b013e3182056b1c.
10
Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.根治性手术切除后可切除性胰腺导管腺癌患者早期复发的术前危险因素。
Hepatobiliary Pancreat Dis Int. 2018 Oct;17(5):450-455. doi: 10.1016/j.hbpd.2018.09.003. Epub 2018 Sep 7.

引用本文的文献

1
Long-Term Outcomes of Neoadjuvant Therapy Versus Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma.新辅助治疗与直接手术治疗可切除胰腺导管腺癌的长期结果。
Cancer Med. 2024 Nov;13(22):e70363. doi: 10.1002/cam4.70363.
2
The Difficulty of Detecting Occult Metastases in Patients with Potentially Resectable Pancreatic Cancer: Development and External Validation of a Preoperative Prediction Model.检测潜在可切除胰腺癌患者隐匿性转移的难度:术前预测模型的开发与外部验证
J Clin Med. 2024 Mar 14;13(6):1679. doi: 10.3390/jcm13061679.
3
Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer.
揭示胰腺癌手术切除后早期复发的临床病理特征。
Sci Rep. 2024 Feb 5;14(1):2942. doi: 10.1038/s41598-024-52909-4.
4
Effect of the preoperative prognostic nutritional index on the long-term prognosis in patients with borderline resectable pancreatic cancer after pancreaticoduodenectomy.术前预后营养指数对交界可切除胰腺癌患者胰十二指肠切除术后长期预后的影响。
Front Oncol. 2023 May 1;13:1098459. doi: 10.3389/fonc.2023.1098459. eCollection 2023.
5
Local Ablative Therapy Associated with Immunotherapy in Locally Advanced Pancreatic Cancer: A Solution to Overcome the Double Trouble?-A Comprehensive Review.局部晚期胰腺癌中局部消融治疗联合免疫治疗:解决双重难题的方案?——一项综述
J Clin Med. 2022 Mar 31;11(7):1948. doi: 10.3390/jcm11071948.
6
MiR-374b-5p inhibits KDM5B-induced epithelial-mesenchymal transition in pancreatic cancer.微小RNA-374b-5p抑制KDM5B诱导的胰腺癌上皮-间质转化。
Am J Cancer Res. 2021 Aug 15;11(8):3907-3920. eCollection 2021.
7
Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis.可切除胰腺癌患者新辅助治疗反应和预后:倾向评分匹配分析。
Gut Liver. 2022 Jan 15;16(1):118-128. doi: 10.5009/gnl20301.
8
A nomogram of preoperative predictors for occult metastasis in patients with PDAC during laparoscopic exploration.用于预测胰腺癌患者腹腔镜探查期间隐匿性转移的术前预测指标列线图。
Gland Surg. 2021 Jan;10(1):279-289. doi: 10.21037/gs-20-605.